IntraMed - Artículos - Enfermedad renal crónica (guía de práctica clínica)
Recomendaciones actualizadas | 10 MAR 14
Enfermedad renal crónica (guía de práctica clínica)
Guía para la evaluación, manejo y tratamiento de la enfermedad renal crónica que no se encuentre bajo terapia de reemplazo renal.
Autor: Dres. Paul E. Stevens, Adeera Levin Ann Intern Med. 2013;158:825-830.
INDICE:  1.  | 2. Referencias
Referencias

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266. [PMID: 11904577]
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
3. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. [PMID: 15205295]
4. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al; GRADE Working Group. Going from evidence to recommendations. BMJ. 2008;336:1049-51. [PMID: 18467413]
5. Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;70:2058-65. [PMID: 17003817]
6. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al; Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331-40. [PMID: 21289598]
7. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al; Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 2011;80:93-104. [PMID: 21289597]
8. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073-81. [PMID: 20483451]
9. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al; Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79:1341-52. [PMID: 21307840]
10. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28. [PMID: 21150873]
11. Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012;156:785-95. [PMID: 22312131]
12. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305:1545-52. [PMID: 21482744]
13. Waheed S, Matsushita K, Sang Y, Hoogeveen R, Ballantyne C, Coresh J, et al. Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2012;60:207-16. [PMID: 22537422]
14. Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, et al. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant. 2010;25:1560-7. [PMID: 20008829]
15. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164-76. [PMID: 15616252]
16. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al; ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813-21. [PMID: 19443635]
17. Viazzi F, Leoncini G, Conti N, Tomolillo C, Giachero G, Vercelli M, et al. Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients. J Hypertens. 2010;28:848-55. [PMID: 20087212]
18. Shastri S, Katz R, Shlipak MG, Kestenbaum B, Peralta CA, Kramer H, et al. Cystatin C and albuminuria as risk factors for development of CKD stage 3:the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2011;57: 832-40. [PMID: 21296473]
19. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol. 2009;20:1069-77. [PMID: 19357254]
20. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46:205-17. [PMID: 19389884]
21. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis. 2012;59:504-12. [PMID: 22284441]
22. O’Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of longterm dialysis. Am J Kidney Dis. 2012;59:513-22. [PMID: 22305760]
23. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. One-year change in kidney function is associated with an increased mortality risk. Am J Nephrol. 2012;36:41-9. [PMID: 22699706]
24. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant. 2012;27:3835-43. [PMID: 22764191]
25. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013. [PMID: 23344477]
26. Kidney Disease: Improving Global Outcomes (KDIGO) BP Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337-414.
27. Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GL, et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol. 2006;26:268-75. [PMID: 16763384]
28. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:1565-74. [PMID: 19808241]
29. Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I. A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study. Hypertens Res. 2012. [PMID: 23171953]
30. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012;60:850-86. [PMID: 23067652]
31. Bedford M, Farmer C, Levin A, Ali T, Stevens P. Acute kidney injury and CKD: chicken or egg? [Editorial]. Am J Kidney Dis. 2012;59:485-91. [PMID: 22444492]
32. Herzog CA, Asinger RW, Berger AK, Charytan DM, Dı´ez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80: 572-86. [PMID: 21750584]
33. Burgos-Calderon R, Depine S. Systematic approach for the management of chronic kidney disease: moving beyond chronic kidney disease classification. Curr Opin Nephrol Hypertens. 2010;19:208-13. [PMID: 19779338]
34. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006;116:288-96. [PMID: 16453013]
35. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al; SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181-92. [PMID: 21663949]

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Dra. Mayra Joana Ger Herrera   Hace 2 meses
Hola doc ese es el resumen de guia 2013 IRC
Dra. Maria De Los Angeles Huerta Jarquin   Hace 11 meses
muchas gracias por mantenernos actualizados, me parece de mucha valor la tabla que nos ofrecen para tener unificado y actualizado el criterio de clasificación, ya que yo pienso que es básico el tratamiento del paciente renal en cualquier lugar del mundo. Saludos
Dr. Hugo Eduardo Curti   Hace 11 meses
Para pasar a PDF o a doc o a txt, simplemente hay que seleccionar el texto, "copiar" y luego "pegar" en un editor de texto o PDF.
Dr. Daniel Rivera Mendoza   Hace 12 meses
Mi agradecimiento por la totalidad de los Contenidos.
Dr. Antonio Rene Romero Vera   Hace 1 año
Buenas Noches, Continuo reiterando mi agradecimiento, para los integrantes de Intramed, ya que día a día se interesan en la actualización de los médicos, que nos nos encontramos en las áreas de primero contacto Hospitalario, los artículos son muy significativos .
Enf. EULALIA MEDINA DIAZ   Hace 1 año
gracias por mantenernos actualizados, son aportes muy importantes para la vida académica
Dr. Senen Osvaldo Martinez Rodriguez   Hace 1 año
CONSIDERO QUE SE TRATA DE UN TEMA ACTUALMENTE IMPACTANTE,PUES ESTAMOS DE ACUERDO QUE LA ERC ESTA INCRECENTO,AUNQUE COMPARTO EL CRITERIO QUE LA CISTATINA C,NO ESTA ALCANCE DE LA MAYORIA DE NUESTROS LABORATORIOS,PRINCIPALMENTE EN PAISES SUB Y EN VIA DE DESARROLLO,PERO LO QUE SI ES EVIDENTE ES QUE TENEMOS QUE TRABAJAR EN LA PREVENCION Y EL TRATAMIENTO DE LAS ENFERMEDADES COMO LA HTA,DM Y FACTORES DE RIESGO QUE REPERCUTEN EN EL DAÑO RENAL Y CONTROLAR LA MISMA.LOS FELICITO,PUES CADA VEZ NOS ALEGRAN CON REVISIONES ACTUALIZADAS.
Dra. Griselda Aquino   Hace 1 año
como lo puedo bajar en pdf?
Excelente articulo
Dr. Pedro Bacardi Zapata   Hace 1 año
Muy interesante, les felicito por este artículo.
Dr. onel valencia mendoza   Hace 1 año
como bajarlos en pdf??
Dr. Antonio Enrique Brito   Hace 1 año
(disculpen el error anterior). agradecer a la Dra. Marta Papponetti
quien tan amablemente realizo la traducción de esta guía.
Dr. Antonio Enrique Brito   Hace 1 año
Excelente articulo, sobre todo agradecer la gentileza de la Dra. Marta Papponetti
quien tan
Los más...
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014